NEW YORK, Jan 4 (Reuters) - A U.S. federal judge has denied motions to certify classes of users of osteoporosis drug Fosamax who wanted Merck & Co to set up a program to monitor them for an ailment ...

LONDON, ONTARIO--(Marketwired - Apr 10, 2015) - A settlement has been reached which, if approved by the courts and fully implemented, will resolve Fosamax and Fosavance claims across Canada. Class and ...

MONTREAL – A non-profit Montreal-based consumer group wants to launch a class-action suit against pharmaceutical giant Merck Frosst for failing to disclose side effects connected with Fosamax, an ...

Dear Dr. Gott: A friend recently told me that she has stopped taking Fosamax because of reports that it can damage the body. Is this true? Are similar drugs also to blame?